Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Clinical trial NCT04904120 · COMPLETED

Trial details

NCT number: NCT04904120
Sponsor: Perspective Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)Melanoma Stage IV Melanoma, Uveal Melanoma, Mucosal

Start date: 2021-03-05
Primary completion: 2022-09-20
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.